Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonam

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260456A, 560109, 560251, 564 99, C07C14375, A61K 3118

Patent

active

045073201

ABSTRACT:
N,N-Di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine is a potent, selective presynaptic dopaminergic agonist. The compound is prepared by N-sulfonylation of an optionally O-protected derivative of 3-amino-4-hydroxy-N,N-di-n-propylphenethylamine, followed by removal of the protecting group.

REFERENCES:
patent: 3341584 (1967-09-01), Larsen et al.
patent: 3574741 (1971-04-01), Gould et al.
patent: 3660487 (1972-05-01), Larsen et al.
patent: 3701808 (1972-10-01), Hartley et al.
patent: 3758692 (1973-09-01), Larsen et al.
patent: 3801631 (1974-04-01), Comer et al.
patent: 4219568 (1980-08-01), Goldberg et al.
patent: 4404224 (1983-09-01), Asato
Uloth et al., J. Med. Chem., vol. 99, pp. 88-96, (1966).
Larsen et al., CA 71: 30232k, (1969).
H. Sheppard et al., "Cyclic Nucleotides in Disease", University Park Press, 1974.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonam does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonam will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1293875

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.